Pharmaceuticals · Key players

Top Anxiety Disorder Drugs companies

The 5 key players our Anxiety Disorder Drugs report profiles, and other companies free public records show in this market.

Key players in Anxiety Disorder Drugs

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Key players in the Anxiety Disorder Drugs market
#CompanyWebsiteOur reports
1 Pfizer Inc. pfizer.com (opens in a new tab) 2,310 reports
2 Eli Lilly and Company lilly.com (opens in a new tab) 1,056 reports
3 Viatris viatris.com (opens in a new tab) 264 reports
4 Lundbeck — 132 reports
5 MindMed — 66 reports

Also active in Anxiety Disorder Drugs

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Also active in Anxiety Disorder Drugs, from free public records
CompanyWhere public records show them
Aurobindo Pharma
Intra-Cellular Therapies
Deliberate Solutions Inc.
Sandoz
Chartwell RX
Otsuka Holdings Co Ltd
Beijing Union Pharmaceutical Factory Ltd
Hikma Pharmaceuticals PLC
Reunion Neuroscience Inc
Alembic Therapeutics
Myota GmbH
Barr

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.

Top trial sponsors in Anxiety Disorder Drugs

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. Intra-Cellular Therapies 4 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Deliberate Solutions Inc. 3 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Otsuka Holdings Co Ltd 3 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Beijing Union Pharmaceutical Factory Ltd 3 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Reunion Neuroscience Inc 2 active trials on ClinicalTrials.gov (opens in a new tab)
  6. Myota GmbH 2 active trials on ClinicalTrials.gov (opens in a new tab)
  7. Definium Therapeutics US, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  8. HabitAware Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Anxiety Disorder Drugs reports by place

One report for each place. Each tile opens that place's report.

Regions 7

World report Africa report APAC report Europe report Latin America report Middle East report North America report

Countries 26

Australia report Brazil report Canada report China report Ecuador report Egypt report France report Germany report Hong Kong report India report Italy report Japan report Kenya report Malaysia report Mexico report New Zealand report Philippines report Russia report Saudi Arabia report Singapore report South Africa report Spain report Thailand report UAE report UK report US report

Compare all 33 places for Anxiety Disorder Drugs, with active trials

Get the full Anxiety Disorder Drugs report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Buy the full report Request free sample

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.